Gilead Sciences (board member)
E84182
Gilead Sciences is a major American biopharmaceutical company known for developing antiviral drugs, including treatments for HIV, hepatitis C, and other serious diseases.
All labels observed (4)
| Label | Occurrences |
|---|---|
| Gilead Sciences | 19 |
| Gilead Sciences, Inc. | 2 |
| Gilead Sciences (board member) canonical | 1 |
| Gilead Sciences (headquarters) | 1 |
Statements (49)
| Predicate | Object |
|---|---|
| instanceOf |
biopharmaceutical company
ⓘ
public company ⓘ |
| country |
United States of America
ⓘ
surface form:
United States
|
| developed |
bictegravir
ⓘ
emtricitabine ⓘ ledipasvir ⓘ remdesivir ⓘ sofosbuvir ⓘ tenofovir alafenamide ⓘ tenofovir disoproxil fumarate ⓘ velpatasvir ⓘ |
| focusesOn |
COVID-19 treatment
ⓘ
HIV treatment ⓘ antiviral drugs ⓘ hepatitis B treatment ⓘ hepatitis C treatment ⓘ |
| founded | 1987 ⓘ |
| foundedBy |
John C. Martin
ⓘ
Michael L. Riordan ⓘ Other early co-founders and investors ⓘ Paris Panayiotopoulos ⓘ |
| foundedIn |
California, United States
ⓘ
surface form:
California
|
| hasBoardOfDirectors | yes ⓘ |
| headquartersLocation |
Foster City, California
ⓘ
surface form:
Foster City, California, United States
|
| industry |
biotechnology
ⓘ
pharmaceuticals ⓘ |
| isMajorCompanyIn | antiviral drug development ⓘ |
| knownFor |
HIV antiretroviral drugs
ⓘ
development of antiviral therapies ⓘ hepatitis C direct-acting antivirals ⓘ |
| listedOn | NASDAQ ⓘ |
| operatesIn | global market ⓘ |
| product |
Biktarvy
ⓘ
Descovy ⓘ Epclusa ⓘ Harvoni ⓘ Sovaldi ⓘ Truvada ⓘ Veklury ⓘ |
| researchFocus |
infectious diseases
ⓘ
inflammation ⓘ oncology ⓘ |
| revenueSource | prescription drugs ⓘ |
| specializesIn |
COVID-19 therapeutics
ⓘ
HIV/AIDS therapeutics ⓘ inflammatory diseases ⓘ oncology ⓘ viral hepatitis therapeutics ⓘ |
| tickerSymbol | GILD ⓘ |
Referenced by (23)
Full triples — surface form annotated when it differs from this entity's canonical label.
this entity surface form:
Gilead Sciences
this entity surface form:
Gilead Sciences
this entity surface form:
Gilead Sciences
this entity surface form:
Gilead Sciences (headquarters)
this entity surface form:
Gilead Sciences, Inc.
this entity surface form:
Gilead Sciences, Inc.
subject surface form:
Velpatasvir
this entity surface form:
Gilead Sciences
this entity surface form:
Gilead Sciences
this entity surface form:
Gilead Sciences
this entity surface form:
Gilead Sciences
this entity surface form:
Gilead Sciences
this entity surface form:
Gilead Sciences
this entity surface form:
Gilead Sciences
this entity surface form:
Gilead Sciences
this entity surface form:
Gilead Sciences
this entity surface form:
Gilead Sciences
this entity surface form:
Gilead Sciences
this entity surface form:
Gilead Sciences
this entity surface form:
Gilead Sciences